NAFLD: mechanisms, treatments, and biomarkers
F Nassir - Biomolecules, 2022 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …
The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)
Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) remain as one
of the most global problematic metabolic diseases with rapidly increasing prevalence and …
of the most global problematic metabolic diseases with rapidly increasing prevalence and …
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Chronic liver disease (CLD) leads to liver fibrosis; it is associated with approximately two
million annual deaths worldwide and is an enormous health burden.[1, 2] The majority of …
million annual deaths worldwide and is an enormous health burden.[1, 2] The majority of …
Nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation
of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are …
of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are …
Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview
S Marchisello, A Di Pino, R Scicali, F Urbano… - International journal of …, 2019 - mdpi.com
Nonalcoholic Fatty Liver Disease (NAFLD) represents the leading cause of liver disease in
developed countries but its diffusion is currently also emerging in Asian countries, in South …
developed countries but its diffusion is currently also emerging in Asian countries, in South …
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
This review summarizes our current understanding of nonalcoholic fatty liver disease
(NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a …
(NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a …
Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts
M Papatheodoridi, E Cholongitas - Current pharmaceutical …, 2018 - ingentaconnect.com
Nonalcoholic fatty liver disease (NAFLD) ranges from simple hepatic steatosis to non-
alcoholic steatohepatitis (NASH) and cirrhosis. The majority of NAFLD patients do not …
alcoholic steatohepatitis (NASH) and cirrhosis. The majority of NAFLD patients do not …
[HTML][HTML] Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
MV Machado, H Cortez-Pinto - Journal of hepatology, 2013 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) affects one in every three subjects in the
occidental world. The vast majority will not progress, but a relevant minority will develop liver …
occidental world. The vast majority will not progress, but a relevant minority will develop liver …